Success Metrics

Clinical Success Rate
72.7%

Based on 8 completed trials

Completion Rate
73%(8/11)
Active Trials
1(7%)
Results Posted
88%(7 trials)
Terminated
3(21%)

Phase Distribution

Ph not_applicable
1
7%
Ph phase_2
1
7%
Ph phase_4
5
36%
Ph phase_3
2
14%
Ph phase_1
4
29%

Phase Distribution

4

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
4(30.8%)
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
2(15.4%)
Phase 4Post-market surveillance
5(38.5%)
N/ANon-phased studies
1(7.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

8 of 12 finished

Non-Completion Rate

33.3%

4 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(8)
Terminated(4)

Detailed Status

Completed8
Terminated3
Withdrawn1
Active, not recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
72.7%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (30.8%)
Phase 21 (7.7%)
Phase 32 (15.4%)
Phase 45 (38.5%)
N/A1 (7.7%)

Trials by Status

withdrawn17%
completed857%
terminated321%
active_not_recruiting17%
enrolling_by_invitation17%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT03480360Phase 3

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

Active Not Recruiting
NCT02081755Phase 4

Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer

Enrolling By Invitation
NCT02226341Phase 4

ACTHar in the Treatment of Lupus Nephritis

Terminated
NCT00933231Phase 3

Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

Completed
NCT00911274Phase 1

Mycophenolate Mofetil 250 mg Capsules Under Fasting Conditions

Completed
NCT00910663Phase 1

Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions

Completed
NCT00908128Phase 1

Mycophenolate Mofetil Tablets Under Fed Conditions

Completed
NCT04002115Phase 2

Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML

Terminated
NCT05195086

A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt

Completed
NCT00336817Not Applicable

A Prospective Study on the Tolerability and Efficacy of the de Novo Use of Myfortic in Liver Transplant Recipients

Completed
NCT02058875Phase 4

Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring

Withdrawn
NCT02981290Phase 1

Study to Compare the Pharmacokinetics of Mycophenolate Mofetil Metabolites From Four Tablet Formulations in Healthy Participants

Completed
NCT00217152Phase 4

A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors

Terminated
NCT00650468Phase 4

A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14